Work

A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity

Year: 1994

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v83.7.1760.1760

Authors: PC Caron, JG Jurcic, AM Scott, RD Finn, CR Divgi, MC Graham, IM Jureidini, G Sgouros, D Tyson, LJ Old

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1587961927, Improving specificity of therapeutic antibodies for cancer., Targeted antigen receptor treatment of cancer, G3614345488

OpenAlex ID: W267300006

FWCI: 5.184

Cites: 26

Cited by: 181

Related to: 10